The UL4 null mutation alleviates inflammasome activation in PRV-infected cells. by Xiaohua Zhang (350570)

The protocol of the maximal cycle-ergometer test. by Kazufumi Hisamoto (21416905)

“…Therefore, we aimed to investigate whether mild hyperbaric hyperoxia enhances aerobic capacity and decreases cardiopulmonary stress during exercise with a particular focus on the ventilatory threshold (VT). …”

Schematic of the experimental design of the pH and temperature-controlled culture experiment in Schiller Coastal Studies Center (SCSC; Bowdoin College, Orr’s Island, ME). by Teagan McMahon (20108036)

The UL4 mutation alleviated inflammation in PRV-infected mice. by Xiaohua Zhang (350570)

The UL4 mutation alleviates inflammasome activation and pyroptosis in PRV-infected cells. by Xiaohua Zhang (350570)

Impact of sludge dosage on HPST. by Peng Zhao (128233)

“…The model optimization and experimental validation showed that the optimal HPST conditions for treating domestic sewage were as follows: the dosage of polyaluminum chloride (PAC) was 1.70 g/L, cationic polyacrylamide (CPAM) dosage was 2.35 mg/L, sewage pH was maintained at 8.0, sludge dosage was 10 mL/L, stirring time lasted for 5 minutes, and settling time lasted for 30 minutes. As a result of these optimized conditions, the turbidity of treated sewage decreased to 1.19 NTU.…”

Impact of settling time on HPST. by Peng Zhao (128233)

“…The model optimization and experimental validation showed that the optimal HPST conditions for treating domestic sewage were as follows: the dosage of polyaluminum chloride (PAC) was 1.70 g/L, cationic polyacrylamide (CPAM) dosage was 2.35 mg/L, sewage pH was maintained at 8.0, sludge dosage was 10 mL/L, stirring time lasted for 5 minutes, and settling time lasted for 30 minutes. As a result of these optimized conditions, the turbidity of treated sewage decreased to 1.19 NTU.…”

ANOVAs for the response surface of Eq (2). by Peng Zhao (128233)

“…The model optimization and experimental validation showed that the optimal HPST conditions for treating domestic sewage were as follows: the dosage of polyaluminum chloride (PAC) was 1.70 g/L, cationic polyacrylamide (CPAM) dosage was 2.35 mg/L, sewage pH was maintained at 8.0, sludge dosage was 10 mL/L, stirring time lasted for 5 minutes, and settling time lasted for 30 minutes. As a result of these optimized conditions, the turbidity of treated sewage decreased to 1.19 NTU.…”

Impact of CPAM dosage on HPST. by Peng Zhao (128233)

“…The model optimization and experimental validation showed that the optimal HPST conditions for treating domestic sewage were as follows: the dosage of polyaluminum chloride (PAC) was 1.70 g/L, cationic polyacrylamide (CPAM) dosage was 2.35 mg/L, sewage pH was maintained at 8.0, sludge dosage was 10 mL/L, stirring time lasted for 5 minutes, and settling time lasted for 30 minutes. As a result of these optimized conditions, the turbidity of treated sewage decreased to 1.19 NTU.…”

Impact of sewage pH on HPST. by Peng Zhao (128233)

“…The model optimization and experimental validation showed that the optimal HPST conditions for treating domestic sewage were as follows: the dosage of polyaluminum chloride (PAC) was 1.70 g/L, cationic polyacrylamide (CPAM) dosage was 2.35 mg/L, sewage pH was maintained at 8.0, sludge dosage was 10 mL/L, stirring time lasted for 5 minutes, and settling time lasted for 30 minutes. As a result of these optimized conditions, the turbidity of treated sewage decreased to 1.19 NTU.…”

Impact of PAC dosage on HPST. by Peng Zhao (128233)

“…The model optimization and experimental validation showed that the optimal HPST conditions for treating domestic sewage were as follows: the dosage of polyaluminum chloride (PAC) was 1.70 g/L, cationic polyacrylamide (CPAM) dosage was 2.35 mg/L, sewage pH was maintained at 8.0, sludge dosage was 10 mL/L, stirring time lasted for 5 minutes, and settling time lasted for 30 minutes. As a result of these optimized conditions, the turbidity of treated sewage decreased to 1.19 NTU.…”

The UL4 null mutation alleviated inflammasome activation in PRV-infected cells. by Xiaohua Zhang (350570)

All data points from S1 to S5 Figs as well as the supplementary method table. by Sara Hijazi (21656615)

The ROC curves and AUC values of the diagnostic model. by Zhe Wu (582498)

Limma differential analysis results for IS and OSA. by Zhe Wu (582498)

Co-expression network of IS and OSA. by Zhe Wu (582498)

Histopathological appearance of the liver. by Ayça Toprak-Semiz (22582110)

Effect of KV3 modulation on PV interneuron firing frequency and on autaptic release. by Sara Hijazi (21656615)

Histopathological appearance of the heart. by Ayça Toprak-Semiz (22582110)

GSVA pathway scores for IS and OSA. by Zhe Wu (582498)